Recombinant Rhesus Macaque ETF1 Protein, His (Fc)-Avi-tagged
Cat.No. : | ETF1-1333R |
Product Overview : | Recombinant Rhesus Macaque ETF1 with His (Fc)-Avi tag was expressed and purified |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Rhesus Macaque |
Tag : | His&Fc&Avi |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method |
Purity : | ≥85% by SDS-PAGE |
Stability : | Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
Storage Buffer : | PBS buffer |
Gene Name : | ETF1 eukaryotic translation termination factor 1 [ Macaca mulatta (Rhesus monkey) ] |
Official Symbol : | ETF1 |
Synonyms : | ETF1; eukaryotic peptide chain release factor subunit 1; |
Gene ID : | 714449 |
mRNA Refseq : | NM_001266474 |
Protein Refseq : | NP_001253403 |
UniProt ID : | F7CTK0 |
Products Types
◆ Recombinant Protein | ||
ETF1-3514H | Recombinant Human ETF1 Protein, GST-tagged | +Inquiry |
Etf1-2878M | Recombinant Mouse Etf1 Protein, Myc/DDK-tagged | +Inquiry |
ETF1-1815R | Recombinant Rat ETF1 Protein, His (Fc)-Avi-tagged | +Inquiry |
ETF1-5893H | Recombinant Human ETF1 protein, MYC/DDK-tagged | +Inquiry |
ETF1-1508R | Recombinant Rhesus monkey ETF1 Protein, His-tagged | +Inquiry |
◆ Lysates | ||
ETF1-6533HCL | Recombinant Human ETF1 293 Cell Lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewWhat sets this protein apart is the outstanding technical support provided by the manufacturer.
Its versatility allows me to explore its diverse roles in various biochemical and biological processes accurately.
The ETF1 Protein is of exceptional quality and is precisely tailored to meet my experimental requirements.
Q&As (5)
Ask a questionThere may be clinical trials evaluating potential treatments or interventions for ETF1 protein disorders, and individuals and families affected by these disorders can consider participating in such trials.
Symptoms may include muscle weakness, lethargy, hypoglycemia, metabolic acidosis, and in some cases, developmental delays and neurological symptoms.
Yes, prenatal testing through genetic screening can detect mutations in the ETF1 gene, allowing for early intervention and management.
Diagnosis typically involves biochemical testing, genetic testing, and metabolic screening to identify abnormalities in fatty acid metabolism.
Yes, ETF1 protein disorders can affect individuals of all ages, from newborns to adults, and may present with different symptoms at different stages of life.
Ask a Question for All ETF1 Products
Required fields are marked with *
My Review for All ETF1 Products
Required fields are marked with *
Inquiry Basket